amiodarone has been researched along with Cytomegalic Inclusion Disease in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pulmonary diffusing capacity for carbon monoxide (DLCO) is reduced in chronic heart failure and remains decreased after heart transplantation." | 3.70 | Lung membrane diffusing capacity, heart failure, and heart transplantation. ( Charloux, A; Epailly, E; Frans, A; Lampert, E; Lonsdorfer, J; Mettauer, B; Oswald, M; Piquard, F; Zhao, QM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mettauer, B | 1 |
| Lampert, E | 1 |
| Charloux, A | 1 |
| Zhao, QM | 1 |
| Epailly, E | 1 |
| Oswald, M | 1 |
| Frans, A | 1 |
| Piquard, F | 1 |
| Lonsdorfer, J | 1 |
1 other study available for amiodarone and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Lung membrane diffusing capacity, heart failure, and heart transplantation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Carbon Monoxide; Case-Control Studies; Cytomegalovirus In | 1999 |